Skip to main content
. 2000 Feb;38(2):789–794. doi: 10.1128/jcm.38.2.789-794.2000

TABLE 2.

Antimicrobial susceptibility testing of B. hinzii and B. avium by three methods

Antibiotica Method Susceptibilityb
B. hinzii BC-306 B. hinzii LMG13501T B. hinzii BC-305 B. avium ATCC 35086T
Ampicillin* Disk R (9) R (13) R (11) S (30)
Ampicillin* E-test I (16) I (16) I (16) S (0.5)
Ampicillin* Micro brothc R (32) R (32) R (32) S (<1)
Ampicillin-sulbactam Disk R (11) I (14) I (14) S (33)
Ampicillin-sulbactam E-test I (16/8) I (16/8) I (16/8) S (0.5)
Ampicillin-sulbactam Micro broth I (16/8) R (32/16) R (32/16) S (<2/1)
Amoxicillin-clavulanic acid* Disk I (17) S (21) S (20) S (34)
Amoxicillin-clavulanic acid* E-test R (32) R (16) R (16) S (0.5)
Ticarcillin Disk I (17) S (21) S (20) S (36)
Ticarcillin Micro broth I (32) I (32) I (64) S (<4)
Ticarcillin-clavulanic acid Disk S (21) S (23) S (23) S (36)
Ticarcillin-clavulanic acid E-test I (32) I (32) I (64) S (0.75)
Ticarcillin-clavulanic acid Micro broth S (16) S (16) S (16) S (<4)
Piperacillin Disk S (35) S (37) S (36) S (37)
Piperacillin Micro broth S (<4) S (<4) S (<4) S (<4)
Piperacillin-tazobactam Disk S (35) S (37) S (36) S (38)
Piperacillin-tazobactam E-test S (1) S (1) S (1) S (1)
Piperacillin-tazobactam Micro broth S (<4/4) S (<4/4) S (<4/4) S (<4/4)
Cefazolin* Disk R (10) R (10) R (13) I (17)
Cephalotin* Disk S (22) S (24) S (25) S (31)
Cefotetan* Disk R (6) R (6) R (6) S (20)
Cefuroxime* Disk R (6) R (6) R (6) I (16)
Ceftriaxone Disk I (14) R (13) I (15) S (28)
Ceftriaxone E-test R (64) R (64) R (64) S (4)
Ceftriaxone Micro broth I (32) I (32) I (32) S (2)
Cefotaxime Micro broth I (32) I (32) I (32) S (2)
Ceftazidime Disk S (26) S (26) S (27) S (31)
Ceftazidime E-test S (4) S (4) S (4) S (2)
Ceftazidime Micro broth S (2) S (2) S (2) S (<1)
Cefepime Disk S (25) S (27) S (27) S (30)
Cefepime E-test S (8) S (8) S (8) S (4)
Cefepime Micro broth S (4) S (4) S (4) S (2)
Imipenem Disk S (30) S (30) S (30) S (26)
Imipenem E-test S (2) S (2) S (2) S (2)
Imipenem Micro broth S (1) S (1) S (1) S (1)
Aztreonam Disk R (6) R (6) R (6) I (17)
Aztreonam Micro broth R (32) R (>32) R (32) I (16)
Chloramphenicol Disk R (10) I (13) R (10) S (2)
Tetracycline Disk S (19) S (25) S (25) S (32)
Trimethoprim-sulfamethoxazole Disk S (33) S (34) S (35) S (35)
Trimethoprim-sulfamethoxazoled E-test S (0.047) S (0.047) S (0.023) S (0.047)
Ciprofloxacin Disk I (17) I (19) I (18) S (23)
Ciprofloxacin E-test R (4) R (4) R (4) I (2)
Ciprofloxacin Micro broth I (2) I (2) I (2) S (1)
Levofloxacin Disk S (20) S (23) S (22) S (26)
Levofloxacin E-test S (2) S (2) S (2) S (0.5)
Gentamicin Disk S (22) S (19) S (20) S (24)
Gentamicin E-test S (2) S (4) S (4) S (2)
Gentamicin Micro broth S (4) S (4) S (4) S (2)
Amikacin Disk S (24) S (23) S (22) S (22)
Amikacin Micro broth S (8) S (8) S (8) S (<4)
Tobramycin Disk S (18) S (15) S (15) S (22)
Tobramycin Micro broth R (8) R (16) R (16) S (2)
Netilmycin Disk S (25) S (23) S (22) S (26)
a

Results with antibiotics marked by asterisk were interpreted according to NCCLS breakpoints for Enterobacteriaceae; all others were interpreted according to NCCLS breakpoints for nonfermenting gram-negative rods; S, susceptible; I, intermediate; R, resistant. 

b

Numbers in parentheses for the disk diffusion method indicate the diameters of inhibition zones (in millimeters); numbers in parentheses for the E-test and broth microdilution method indicate the MICs (in micrograms per milliliter). 

c

Micro broth, broth microdilution method. 

d

For trimethoprim-sulfamethoxazole, the result is expressed as the MIC of trimethoprim.